$476 Million is the total value of Integral Health Asset Management, LLC's 61 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 95.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CYTK | Buy | CYTOKINETICS INC | $18,328,000 | +8.1% | 400,000 | +14.3% | 3.85% | +16.8% |
| Sell | CYTOKINETICS INCcall | $18,328,000 | -17.1% | 400,000 | -12.3% | 3.85% | -10.4% | |
| MRNA | New | MODERNA INC | $17,962,000 | – | 100,000 | +100.0% | 3.77% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $17,593,300 | +94.0% | 170,000 | +58.9% | 3.69% | +109.6% |
| MRK | Sell | MERCK & CO INC | $16,642,500 | +4.5% | 150,000 | -18.9% | 3.49% | +12.9% |
| DGX | New | QUEST DIAGNOSTICS INC | $15,644,000 | – | 100,000 | +100.0% | 3.28% | – |
| INSP | Buy | INSPIRE MED SYS INC | $15,112,800 | +113.0% | 60,000 | +50.0% | 3.17% | +130.2% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $15,105,000 | +26.8% | 750,000 | +36.4% | 3.17% | +37.0% |
| CI | New | CIGNA CORP NEW | $14,910,300 | – | 45,000 | +100.0% | 3.13% | – |
| New | MADRIGAL PHARMACEUTICALS INCput | $14,512,500 | – | 50,000 | +100.0% | 3.05% | – | |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $14,089,000 | – | 100,000 | +100.0% | 2.96% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $13,730,400 | -1.8% | 360,000 | +0.8% | 2.88% | +6.1% |
| EXAS | Buy | EXACT SCIENCES CORP | $13,615,250 | +179.3% | 275,000 | +83.3% | 2.86% | +201.8% |
| GH | Buy | GUARDANT HEALTH INC | $12,920,000 | -46.7% | 475,000 | +5.6% | 2.71% | -42.4% |
| ANTM | Sell | ELEVANCE HEALTH INC | $12,824,250 | -29.4% | 25,000 | -37.5% | 2.69% | -23.7% |
| QURE | Buy | UNIQURE NV | $12,468,500 | +53.5% | 550,000 | +27.0% | 2.62% | +65.8% |
| ISRG | New | INTUITIVE SURGICAL INC | $11,675,400 | – | 44,000 | +100.0% | 2.45% | – |
| HCA | New | HCA HEALTHCARE INC | $10,318,280 | – | 43,000 | +100.0% | 2.17% | – |
| GILD | New | GILEAD SCIENCES INC | $10,302,000 | – | 120,000 | +100.0% | 2.16% | – |
| SNY | Sell | SANOFIsponsored adr | $9,686,000 | +1.9% | 200,000 | -20.0% | 2.03% | +10.1% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $9,492,000 | – | 140,000 | +100.0% | 1.99% | – |
| RLAY | Buy | RELAY THERAPEUTICS INC | $9,337,500 | -30.4% | 625,000 | +4.2% | 1.96% | -24.8% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $9,110,300 | +45.2% | 115,000 | +27.8% | 1.91% | +56.8% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $8,317,750 | -40.6% | 35,000 | -50.0% | 1.75% | -35.9% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $8,287,500 | – | 65,000 | +100.0% | 1.74% | – |
| CNC | Sell | CENTENE CORP DEL | $8,201,000 | -53.2% | 100,000 | -55.6% | 1.72% | -49.4% |
| ABBV | New | ABBVIE INC | $8,080,500 | – | 50,000 | +100.0% | 1.70% | – |
| Buy | VENTYX BIOSCIENCES INC | $6,885,900 | +97.2% | 210,000 | +110.0% | 1.44% | +113.1% | |
| PEN | New | PENUMBRA INC | $6,673,800 | – | 30,000 | +100.0% | 1.40% | – |
| CAH | Sell | CARDINAL HEALTH INC | $6,457,080 | -51.6% | 84,000 | -58.0% | 1.36% | -47.7% |
| REPL | Buy | REPLIMUNE GROUP INC | $5,984,000 | +73.2% | 220,000 | +10.0% | 1.26% | +87.2% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $5,827,500 | +8.9% | 370,000 | +8.8% | 1.22% | +17.6% |
| VKTX | New | VIKING THERAPEUTICS INC | $5,640,000 | – | 600,000 | +100.0% | 1.18% | – |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $5,273,100 | +41.9% | 270,000 | +38.5% | 1.11% | +53.3% |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $5,233,500 | -25.2% | 150,000 | +20.0% | 1.10% | -19.2% |
| TFX | New | TELEFLEX INCORPORATED | $4,992,600 | – | 20,000 | +100.0% | 1.05% | – |
| COO | New | COOPER COS INC | $4,960,050 | – | 15,000 | +100.0% | 1.04% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $4,670,000 | – | 125,000 | +100.0% | 0.98% | – |
| KDNY | New | CHINOOK THERAPEUTICS INC | $4,585,000 | – | 175,000 | +100.0% | 0.96% | – |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $4,430,400 | +9.4% | 240,000 | +60.0% | 0.93% | +18.2% |
| DOCS | New | DOXIMITY INCcl a | $4,396,360 | – | 131,000 | +100.0% | 0.92% | – |
| NVRO | Buy | NEVRO CORP | $4,316,400 | -7.4% | 109,000 | +9.0% | 0.91% | +0.1% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $3,992,670 | +194.2% | 327,000 | +151.5% | 0.84% | +217.4% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $3,836,000 | -51.0% | 70,000 | -69.6% | 0.80% | -47.1% |
| PTCT | Sell | PTC THERAPEUTICS INC | $3,817,000 | -53.4% | 100,000 | -38.7% | 0.80% | -49.6% |
| ARGX | New | ARGENX SEsponsored adr | $3,788,300 | – | 10,000 | +100.0% | 0.80% | – |
| NTRA | New | NATERA INC | $3,494,790 | – | 87,000 | +100.0% | 0.73% | – |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $3,367,000 | -76.7% | 100,000 | -77.3% | 0.71% | -74.8% |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $3,229,150 | – | 85,000 | +100.0% | 0.68% | – |
| PRVA | New | PRIVIA HEALTH GROUP INC | $2,952,300 | – | 130,000 | +100.0% | 0.62% | – |
| KROS | New | KEROS THERAPEUTICS INC | $2,881,200 | – | 60,000 | +100.0% | 0.60% | – |
| FGEN | New | FIBROGEN INC | $2,803,500 | – | 175,000 | +100.0% | 0.59% | – |
| KYMR | New | KYMERA THERAPEUTICS INC | $2,496,000 | – | 100,000 | +100.0% | 0.52% | – |
| DVA | Sell | DAVITA INC | $2,464,110 | -60.3% | 33,000 | -56.0% | 0.52% | -57.1% |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $2,200,000 | – | 20,000 | +100.0% | 0.46% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $2,158,200 | – | 109,000 | +100.0% | 0.45% | – |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $1,873,400 | -70.1% | 20,000 | -60.0% | 0.39% | -67.7% |
| TGTX | New | TG THERAPEUTICS INC | $1,774,500 | – | 150,000 | +100.0% | 0.37% | – |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $1,426,800 | – | 40,000 | +100.0% | 0.30% | – |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $792,180 | +93.7% | 243,000 | +120.9% | 0.17% | +110.1% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $164,320 | -69.1% | 416,000 | +10.3% | 0.03% | -67.0% |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.20% | – |
| Exit | CINCOR PHARMA INC | $0 | – | -50,000 | -100.0% | -0.32% | – | |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -30,000 | -100.0% | -0.36% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDGS | $0 | – | -130,000 | -100.0% | -0.37% | – |
| DSGN | Exit | DESIGN THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -0.41% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.55% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -700,000 | -100.0% | -0.57% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -33,000 | -100.0% | -0.62% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -92,000 | -100.0% | -0.64% | – |
| LFST | Exit | LIFESTANCE HEALTH GROUP INC | $0 | – | -525,000 | -100.0% | -0.68% | – |
| SIBN | Exit | SI-BONE INC | $0 | – | -200,000 | -100.0% | -0.68% | – |
| DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -115,000 | -100.0% | -0.69% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -300,000 | -100.0% | -0.70% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -200,000 | -100.0% | -0.87% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -70,000 | -100.0% | -0.93% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.95% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -30,000 | -100.0% | -1.11% | – |
| PODD | Exit | INSULET CORP | $0 | – | -25,000 | -100.0% | -1.11% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -93,000 | -100.0% | -1.19% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -130,000 | -100.0% | -1.30% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -375,000 | -100.0% | -1.31% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -500,000 | -100.0% | -1.33% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -15,000 | -100.0% | -1.47% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -30,000 | -100.0% | -1.50% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -25,000 | -100.0% | -1.57% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -90,000 | -100.0% | -1.86% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -30,000 | -100.0% | -1.98% | – |
| PRGO | Exit | PERRIGO CO PLC | $0 | – | -320,000 | -100.0% | -2.22% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -130,000 | -100.0% | -2.41% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -50,000 | -100.0% | -2.59% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -350,000 | -100.0% | -2.63% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -220,000 | -100.0% | -2.79% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -300,000 | -100.0% | -3.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.